跳至主要内容
临床试验/NL-OMON38936
NL-OMON38936已完成不适用

Comparison of two modified release (M.R.) formulations of S16257 22.5 mg o.d, with S 16257 immediate release tablet 7.5 mg b.i.d and linearity assessment of S 16257 pharmacokinetic over 7.5, 22.5 and 30 mg o.d doses of one of the M.R. formulations An open-label, phase I, single-centre, randomised five-way crossover study in healthy participants. - S 16257 comparative PK study

Institut de Recherches Internationales Servier I.R.I.S0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • healthy male and female Caucasian subjects, non-smoking or smoking less then 10 cigarettes per day, 18 - 65 yrs, inclusive, 18.5 - 30.0 kg/m2, inclusive

排除标准

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 3 months from the start of the study.

研究者

发起方
Institut de Recherches Internationales Servier I.R.I.S

相似试验